S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Verve Therapeutics (VERV) Short Interest Ratio & Short Volume

$6.66
-0.08 (-1.19%)
(As of 04/18/2024 ET)

Verve Therapeutics Short Interest Data

Current Short Volume
15,360,000 shares
Previous Short Volume
14,100,000 shares
Change Vs. Previous Month
+8.94%
Dollar Volume Sold Short
$203.98 million
Short Interest Ratio / Days to Cover
12.3
Last Record Date
March 31, 2024
Outstanding Shares
83,620,000 shares
Float Size
54,790,000 shares
Short Percent of Float
28.03%
Today's Trading Volume
1,246,419 shares
Average Trading Volume
1,242,455 shares
Today's Volume Vs. Average
100%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Verve Therapeutics ?

Sign up to receive the latest short interest report for Verve Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VERV Short Interest Over Time

VERV Days to Cover Over Time

VERV Percentage of Float Shorted Over Time

Verve Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202415,360,000 shares $203.98 million +8.9%28.0%12.3 $13.28
3/15/202414,100,000 shares $194.72 million +12.6%25.7%12.8 $13.81
2/29/202412,520,000 shares $213.47 million -0.6%22.9%11 $17.05
2/15/202412,590,000 shares $167.20 million +1.8%23.0%10.7 $13.28
1/31/202412,370,000 shares $133.84 million +0.1%21.9%7.7 $10.82
1/15/202412,360,000 shares $157.84 million +5.4%21.9%7.2 $12.77
12/31/202311,730,000 shares $163.52 million +4.4%22.9%7 $13.94
12/15/202311,240,000 shares $155.79 million -21.8%21.9%6.7 $13.86
11/30/202314,380,000 shares $162.21 million +7.7%28.0%9.2 $11.28
11/15/202313,350,000 shares $153.39 million +5.2%30.8%9.5 $11.49
10/31/202312,690,000 shares $152.79 million +11.1%29.6%13.2 $12.04
10/15/202311,420,000 shares $133.61 million -6.2%26.7%16 $11.70
9/30/202312,180,000 shares $161.51 million +2.0%28.4%18.2 $13.26
9/15/202311,940,000 shares $151.40 million +0.2%27.9%19.4 $12.68
8/31/202311,920,000 shares $153.41 million +6.7%28.2%18.6 $12.87
8/15/202311,170,000 shares $176.49 million +4.5%26.4%17.9 $15.80
7/31/202310,690,000 shares $219.04 million -10.2%26.5%17.2 $20.49
7/15/202311,900,000 shares $237.29 million +0.5%29.5%19.2 $19.94
6/30/202311,840,000 shares $222 million +2.5%29.3%18.3 $18.75
6/15/202311,550,000 shares $229.15 million -6.6%28.6%16.6 $19.84
5/31/202312,360,000 shares $191.33 million -1.9%30.6%17.8 $15.48
5/15/202312,600,000 shares $222.52 million -4.0%31.2%16.7 $17.66
4/30/202313,120,000 shares $209.00 million -2.3%34.5%17.5 $15.93
4/15/202313,430,000 shares $202.12 million -0.5%35.3%17.9 $15.05
3/31/202313,500,000 shares $194.67 million -1.5%35.6%18.3 $14.42
3/15/202313,700,000 shares $233.59 million No Change36.1%19.3 $17.05
2/28/202313,700,000 shares $260.30 million +1.0%36.1%17 $19.00
2/15/202313,570,000 shares $294.74 million +5.9%35.9%17.6 $21.72
1/31/202312,820,000 shares $291.66 million +0.2%31.6%13.9 $22.75
1/15/202312,790,000 shares $293.40 million +2.6%31.5%13.3 $22.94
12/30/202212,470,000 shares $241.29 million +13.8%32.5%13 $19.35
12/15/202210,960,000 shares $213.94 million +8.4%29.0%11.1 $19.52
11/30/202210,110,000 shares $234.86 million +1.3%26.7%9.4 $23.23
11/15/20229,980,000 shares $260.08 million -0.7%26.4%9.9 $26.06
10/31/202210,050,000 shares $378.89 million -6.3%26.9%9.6 $37.70
10/15/202210,730,000 shares $327.91 million -11.5%29.7%11.1 $30.56
9/30/202212,130,000 shares $416.67 million +23.0%33.6%10 $34.35
9/15/20229,860,000 shares $409.09 million +2.0%27.3%8.2 $41.49
8/31/20229,670,000 shares $370.94 million +0.8%27.7%8.8 $38.36
8/15/20229,590,000 shares $363.08 million +7.4%27.4%9 $37.86
Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

VERV Short Interest - Frequently Asked Questions

What is Verve Therapeutics' current short interest?

Short interest is the volume of Verve Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 15,360,000 shares of VERV short. 28.03% of Verve Therapeutics' shares are currently sold short. Learn More on Verve Therapeutics' current short interest.

What is a good short interest ratio for Verve Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VERV shares currently have a short interest ratio of 12.0. Learn More on Verve Therapeutics's short interest ratio.

Which institutional investors are shorting Verve Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Verve Therapeutics: Citadel Advisors LLC, PEAK6 Investments LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Verve Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 28.03% of Verve Therapeutics' floating shares are currently sold short.

Is Verve Therapeutics' short interest increasing or decreasing?

Verve Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 15,360,000 shares, an increase of 8.9% from the previous total of 14,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Verve Therapeutics' float size?

Verve Therapeutics currently has issued a total of 83,620,000 shares. Some of Verve Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Verve Therapeutics currently has a public float of 54,790,000 shares.

How does Verve Therapeutics' short interest compare to its competitors?

28.03% of Verve Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Verve Therapeutics: CureVac (5.47%), Mineralys Therapeutics, Inc. (4.82%), Olema Pharmaceuticals, Inc. (14.48%), Korro Bio, Inc. (2.31%), Phathom Pharmaceuticals, Inc. (39.95%), Astria Therapeutics, Inc. (11.37%), Nuvation Bio Inc. (2.10%), Lyell Immunopharma, Inc. (15.53%), GH Research PLC (4.47%), AnaptysBio, Inc. (18.16%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Verve Therapeutics stock?

Short selling VERV is an investing strategy that aims to generate trading profit from Verve Therapeutics as its price is falling. VERV shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Verve Therapeutics?

A short squeeze for Verve Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VERV, which in turn drives the price of the stock up even further.

How often is Verve Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VERV, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:VERV) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners